Repeated contact with subtoxic soman leads to synaptic vulnerability in hippocampus
- PMID: 15352221
- DOI: 10.1002/jnr.20209
Repeated contact with subtoxic soman leads to synaptic vulnerability in hippocampus
Abstract
Soman, an anticholinesterase and dangerous nerve agent, produces convulsions, memory impairment, and cell loss in the brain, especially in the hippocampus. Soman-induced accumulation of acetylcholine initiates mechanisms responsible for the development of incapacitating seizures. The prolonged epileptiform nature of these seizures causes the release of another excitatory neurotransmitter, glutamate, which has been linked to the toxic action of the nerve agent. Here, we tested whether subtoxic soman exposures influence the brain's sensitivity to glutamate-based excitotoxicity. Over a 1-week period, hippocampal slice cultures were exposed daily to a transient level of soman that produced no evidence of synaptic deterioration. After the subtoxic soman treatments, however, the tissue became vulnerable to a brief episode of glutamate receptor overstimulation that normally resulted in little or no excitotoxic damage. In those slice cultures treated with subtoxic soman, a decline in synaptic markers as well as an increase in spectrin breakdown occurred 24 hr after the mild excitotoxic event. Exposure to high soman concentrations alone produced similar synaptic degeneration, but without evident cell death, suggesting that synaptic decline is an early neurotoxicological response to the nerve agent. Interestingly, enhanced excitotoxic sensitivity caused the brain tissue to become susceptible to disparate insults initiated before or after the soman contact. These findings indicate that seemingly innocuous soman exposures leave the hippocampus sensitive to the types of insults implicated in traumatic brain injury and stroke. They also warn that asymptomatic contact with soman may lead to progressive synaptopathogenesis and that early indicators of soman exposure are critical to prevent potential brain injury.
Similar articles
-
3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.Hippocampus. 2006;16(10):834-42. doi: 10.1002/hipo.20214. Hippocampus. 2006. PMID: 16897723
-
Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus.J Neuropathol Exp Neurol. 2007 Sep;66(9):779-88. doi: 10.1097/nen.0b013e3181461ae7. J Neuropathol Exp Neurol. 2007. PMID: 17805008
-
Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons.Exp Neurol. 2005 Jun;193(2):384-93. doi: 10.1016/j.expneurol.2004.12.026. Exp Neurol. 2005. PMID: 15869941
-
Synaptic pharmacology of the hippocampus.Rev Clin Basic Pharm. 1987 Jul-Sep;6(3):189-211. doi: 10.1515/jbcpp.1987.6.3.189. Rev Clin Basic Pharm. 1987. PMID: 3310131 Review.
-
The hippocampus as a common target of neurotoxic agents.Toxicology. 1988 Apr;49(1):137-40. doi: 10.1016/0300-483x(88)90185-0. Toxicology. 1988. PMID: 3287689 Review.
Cited by
-
Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon.J Mol Neurosci. 2017 Sep;63(1):115-122. doi: 10.1007/s12031-017-0963-4. Epub 2017 Aug 12. J Mol Neurosci. 2017. PMID: 28803438
-
Neurotoxins and neurotoxic species implicated in neurodegeneration.Neurotox Res. 2004;6(7-8):615-30. doi: 10.1007/BF03033456. Neurotox Res. 2004. PMID: 15639792 Review.
-
Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.Toxicol Appl Pharmacol. 2009 Oct 15;240(2):124-31. doi: 10.1016/j.taap.2009.07.006. Epub 2009 Jul 14. Toxicol Appl Pharmacol. 2009. PMID: 19615394 Free PMC article.
-
Paraoxon: An Anticholinesterase That Triggers an Excitotoxic Cascade of Oxidative Stress, Adhesion Responses, and Synaptic Compromise.Eur Sci J. 2017 Oct;13:29-37. doi: 10.19044/esj.2017.c1p4. Eur Sci J. 2017. PMID: 29805717 Free PMC article.
-
Retrograde activation of CB1R by muscarinic receptors protects against central organophosphorus toxicity.Neuropharmacology. 2019 Sep 1;155:113-120. doi: 10.1016/j.neuropharm.2019.05.028. Epub 2019 May 24. Neuropharmacology. 2019. PMID: 31132436 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical